Nika Pharmaceuticals, Inc. (OTCPK : NKPH) signed an agreement and plan of merger to acquire Nika BioTechnology, Inc. on February 12, 2024. NKPH will issue 204,205,027 shares of common stock and 5,000,000 shares of Preferred stock in exchange for all of the issued and outstanding shares of both the preferred and common stock of Nika.

Nika Pharmaceuticals, Inc. (OTCPK : NKPH) completed the acquisition of Nika BioTechnology, Inc. on March 1, 2024.